Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 1 Hershey Dr SMITHS FALLS ON K7A 0A8 |
Tel: | N/A |
Website: | https://www.canopygrowth.com |
IR: | See website |
Key People | ||
David Eric Klein Chief Executive Officer, Director | Judy Eun Joo Hong Chief Financial Officer | Christelle Gedeon Chief Legal Officer and Company Secretary |
Business Overview |
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products with a focus on cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. It operates through four segments: Canada cannabis, Storz & Bickel, Rest-of-world cannabis, and This Works. Its CPG portfolio features targeted 24-hour skincare and wellness solutions from This Works, gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. The Storz & Bickel segment includes the production, distribution, and sale of vaporizers. |
Financial Overview |
For the six months ended 30 September 2023, Canopy Growth Corp revenues decreased 35% to C$145.9M. Net loss before extraordinary items decreased 93% to C$158.7M. Revenues reflect Canada segment decrease of 28% to C$112.5M, Germany segment decrease of 8% to C$21.8M. Lower net loss reflects Asset impairment and restructuring costs decrease from C$1.77B (expense) to C$28M (income), FV Adjustments of Financial Investment decrease of 94% to C$17.2M (expense). |
Employees: | 1,621 as of Mar 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $1,189M as of Sep 30, 2023 |
Annual revenue (TTM): | $320.78M as of Sep 30, 2023 |
EBITDA (TTM): | -$330.28M as of Sep 30, 2023 |
Net annual income (TTM): | -$1,132M as of Sep 30, 2023 |
Free cash flow (TTM): | -$519.70M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | $494.79M as of Sep 30, 2023 |
Shares outstanding: | 732,480,532 as of Oct 2, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |